Connective Portfolio Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-630
| Closed | -$449K | – | 55 |
|
|
2024
Q4 | $449K | Sell |
630
-25,000
| -98% | -$17.8M | 0.67% | 51 |
|
|
2024
Q3 | $2.77M | Buy |
25,630
+25,000
| +3,968% | +$2.7M | 4.9% | 5 |
|
|
2024
Q2 | $662K | Hold |
630
| – | – | 1.08% | 37 |
|
|
2024
Q1 | $606K | Hold |
630
| – | – | 1.07% | 39 |
|
|
2023
Q4 | $553K | Hold |
630
| – | – | 1.13% | 33 |
|
|
2023
Q3 | $518K | Hold |
630
| – | – | 1.58% | 29 |
|
|
2023
Q2 | $453K | Sell |
630
-45
| -7% | -$32.4K | 1.12% | 39 |
|
|
2023
Q1 | $555K | Sell |
675
-1,900
| -74% | -$1.56M | 1.76% | 25 |
|
|
2022
Q4 | $1.86M | Buy |
2,575
+500
| +24% | +$361K | 3.96% | 4 |
|
|
2022
Q3 | $1.49M | Buy |
2,075
+725
| +54% | +$522K | 4.76% | 5 |
|
|
2022
Q2 | $798K | Buy |
1,350
+675
| +100% | +$399K | 1.37% | 31 |
|
|
2022
Q1 | $471K | Hold |
675
| – | – | 1.01% | 35 |
|
|
2021
Q4 | $426K | Buy |
+675
| New | +$426K | 0.75% | 43 |
|